Everafenib is a potent BRAF inhibitor that crosses the blood-brain barrier and also inhibits the MAPK pathway. Everafenib inhibits the activity of a range of V600EBRAF melanoma cell lines (IC50: 2-10 nM) and is more effective than Dabrafenib and Vemurafenib. Everafenib was effective in extending the number of days of survival in a mouse model of intracranial metastatic melanoma.
Molecular Weight:
484.01
Formula:
C20H23ClFN5O2S2
Target:
Raf|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
